Fatal haemorrhage following endobronchial ultrasoundtransbronchial needle aspiration: an unfortunate first
Sir, Endobronchial ultrasound-transbronchial needle aspiration (EBUS-TBNA) has revolutionised the investigation of mediastinal lymphadenopathy. [1] [2] [3] [4] In this report, we describe a patient who died within 48 hours of this procedure.
A 61-year-old man with 40 pack-year smoking history presented with dyspnoea, weight loss and hip pain. Drug history included paracetamol, diclofenac, morphine sulphate and amoxicillin. There was no history of bleeding disorders or excess alcohol consumption. EBUS-TBNA of subcarinal (four passes) and right hilar (three passes) lymph nodes was carried out with a 21-gauge needle by an experienced operator who had performed >170 procedures. The proximal bronchial tree appeared normal and the needle was visualised during lymph node sampling at all times without apparent complication. Six hours later, the patient developed haemoptysis of increasingly larger volumes. Repeat blood tests demonstrated no significant fall in haemoglobin but mild prolongation of prothrombin time (PT) and activated ! The Author 2013. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oup.com partial thromboplastin time (APTT) suggestive of factor deficiency. He was treated with oxygen, tranexamic acid, fluids and blood transfusion. Given the putative diagnosis of metastatic lung cancer, requirement for high-flow oxygen and clinical instability, further CT imaging, bronchoscopy or invasive mechanical ventilation was deemed inappropriate. The patient subsequently died following massive haemoptysis. His family did not wish a postmortem examination and this was not pursued further following discussion with the procurator fiscal.
As far as we are aware, this is the first reported death as a direct consequence of or occurring shortly after EBUS-TBNA. The exact cause of the patient's continued haemoptysis is not entirely clear but the relative thrombocytopenia, possible marrow infiltration (with potentially defective platelet function) and prolonged PT and APTT were likely major contributing factors to presumed lymph node bleeding into the bronchial tree. It is unfortunate that a post-mortem was not carried out in order to establish the exact cause of the patient's ultimate demise although features of primary lung adenocarcinoma were found in both nodal stations. A systematic review of 20 studies assessing the safety of EBUS-TBNA reported no serious complications. 3 In the largest of these studies (n = 502 patients), no complications were reported. Only three of the studies reported complications of agitation, cough and presence of blood at the puncture site. Given the case highlighted, clinicians should take extra caution when performing EBUS-TBNA in patients with a combination of thrombocytopenia, metastatic malignancy with possible marrow involvement and hepatic dysfunction. 
